Saurabh Saha, CEO: Centessa Pharmaceuticals CNTA Sell · Filed 25/04/22

Trade details

Type: Insider sale
Amount: $501,475.92
Shares · price: 40,344 sh · $12.43 a share
Held after: 221,017 sh
Stock: Centessa Pharmaceuticals CNTA
Person: Saurabh SahaCEO
Trade date: 25/04/22
Filed: 25/04/22
Days to filing: 0 days

Sold 15.4% of holdings

Share of holding sold: 15.4%

Centessa Pharmaceuticals trades, last 26 weeks

What else happened in Centessa Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 25/03/23~25/05/22

Saurabh Saha's recent trades

Saurabh SahaCEO
Sell10b5-1 planCentessa Pharmaceuticals
Sell10b5-1 plan
Centessa Pharmaceuticals
CNTA
$875.6K
55,000 sh
$875.6K
Filed 25/07/21
Traded 25/07/21
Saurabh SahaCEO
Sell10b5-1 planCentessa Pharmaceuticals
Sell10b5-1 plan
Centessa Pharmaceuticals
CNTA
$694.7K
55,000 sh
$694.7K
Filed 25/06/20
Traded 25/06/20
Saurabh SahaCEO
Sell10b5-1 planCentessa Pharmaceuticals
Sell10b5-1 plan
Centessa Pharmaceuticals
CNTA
$699.1K
55,000 sh
$699.1K
Filed 25/05/20
Traded 25/05/20
Saurabh SahaCEO
Sell10b5-1 planCentessa Pharmaceuticals
Sell10b5-1 plan
Centessa Pharmaceuticals
CNTA
$180.1K
14,656 sh
$180.1K
Filed 25/04/22
Traded 25/04/21
Saurabh SahaCEO
Sell10b5-1 planCentessa Pharmaceuticals
Sell10b5-1 plan
Centessa Pharmaceuticals
CNTA
$918K
55,000 sh
$918K
Filed 25/03/21
Traded 25/03/20

Saurabh Saha, CEO — sold $501.5K of Centessa Pharmaceuticals CNTA · 15.4% of holdings · 10b5-1 plan | Whalegun